Using the TRAP assay, telomerase activity was previously detected in over 9
0% of human pleural mesotheliomas (MMs), but not in mesothelial cell cultur
es (MCCs), suggesting that telomerase re-activation occurs during multi-ste
p mesothelioma carcinogenesis. The present study determined the expression
of the telomerase RNA template (hTERC), the telomerase-associated protein (
hTEP1), and the telomerase catalytic sub-unit (hTERT), in 16 pleural MMs an
d 4 MM-derived cell lines, in two pleural solitary fibrous tumours and in s
ix MCCs. Reverse transcription-polymerase chain reaction analysis revealed
that hTERT mRNA expression parallels the activity status documented by the
TRAP assay, whereas hTERC and hTEP1 mRNA are commonly ex-pressed in all mal
ignant and non-malignant serosal cells and tissues. Three alternatively spa
ced hTERT transcripts were detected in all telomerase-positive samples, whe
reas neither variant could be detected in the MCCs. Detection of the hTERT
protein with a commercially available antibody was not successful. These re
sults indicate that hTERT expression is rate-limiting for human telomerase
activity and that re-activation, rather than up-regulation, of hTERT expres
sion can play a critical role in MM carcinogenesis, While waiting suitable
anti-hTERT antibodies, these results provide information for the design of
hTERT mRNA-specific in situ probes to study telomerase in archived pre-mali
gnant serosal lesions, Copyright (C) 2000 John Whey & Sons, Ltd.